Literature DB >> 22965646

Tongue coblation via the ventral approach for obstructive sleep apnea-hypopnea syndrome surgery.

Tiening Hou1, Sunhong Hu, Xiaohua Jiang.   

Abstract

OBJECTIVES/HYPOTHESIS: To determine the safety and efficacy of tongue Coblation via the ventral approach in the treatment of hypopharyngeal obstruction for patients with obstructive sleep apnea-hypopnea syndrome (OSAHS). STUDY
DESIGN: Prospective case-control study.
METHODS: Tongue Coblation was performed under local anesthesia in one session in 40 inpatients diagnosed with OSAHS with predominant hypopharyngeal obstruction after failed uvulopalatopharyngoplasty. In the ventral approach (n = 20), only one puncture point was applied at the center of lingual frenulum, and 12 radiofrequency volumetric tissue reduction (RFVTR) lesions were implanted in the tongue. In the dorsal approach (n = 20), eight RFVTR lesions were distributed on the tongue. Using portable polysomnography (PSG) and the Epworth sleepiness questionnaire (ESQ), we followed 36 patients for 1 year after the operation. Good outcome was defined as apnea-hypopnea index <20 or reduction >50%.
RESULTS: In the ventral approach, total energy was accumulated to 23,000 J in 12 lesions, with postoperative pain 2-3 by visual analog scale (VAS). There was only one case of moderate venous bleeding and hematoma. The ESQ comparison indicated subjective improvements in patients, and PSG showed a curative effect in 11 of 19 (61.11%, eight of 19 success plus three of 19 responders), with a failure rate of eight of 19. By contrast, in the dorsal approach, total energy was 16,000 J, with postoperative pain 3-4 (VAS). Complications included mild to moderate tongue venous hematoma, severe infection of tongue, and temporary mild glossal deviation. A curative effect was seen in six of 17, with a failure rate of 11 of 17.
CONCLUSIONS: Tongue Coblation via the ventral approach is an effective and safe technique to treat hypopharyngeal obstruction in OSAHS surgery.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22965646     DOI: 10.1002/lary.23556

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  [S2e-guideline: "ENT-specific therapy of obstructive sleep apnea in adults" short version : Sleep Medicine Task Force of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  T Verse; A Dreher; C Heiser; M Herzog; J T Maurer; W Pirsig; K Rohde; N Rothmeier; A Sauter; A Steffen; S Wenzel; B A Stuck
Journal:  HNO       Date:  2016-05       Impact factor: 1.284

2.  ENT-specific therapy of obstructive sleep apnoea in adults : A revised version of the previously published German S2e guideline.

Authors:  T Verse; A Dreher; C Heiser; M Herzog; J T Maurer; W Pirsig; K Rohde; N Rothmeier; A Sauter; A Steffen; S Wenzel; B A Stuck
Journal:  Sleep Breath       Date:  2016-05-14       Impact factor: 2.816

Review 3.  Tongue reduction for OSAHS: TORSs vs coblations, technologies vs techniques, apples vs oranges.

Authors:  Giovanni Cammaroto; Filippo Montevecchi; Giovanni D'Agostino; Ermelinda Zeccardo; Chiara Bellini; Bruno Galletti; Medhat Shams; Hesham Negm; Claudio Vicini
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-24       Impact factor: 2.503

4.  A Comparison of Different Success Definitions in Non-Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea Using Cardiopulmonary Coupling.

Authors:  Woo Hyun Lee; Seung-No Hong; Hong Joong Kim; Chae-Seo Rhee; Chul Hee Lee; In-Young Yoon; Jeong-Whun Kim
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

5.  Trans-oral robotic surgery versus coblation tongue base reduction for obstructive sleep apnea syndrome.

Authors:  Wei-Che Lan; Wen-Dien Chang; Ming-Hsui Tsai; Yung-An Tsou
Journal:  PeerJ       Date:  2019-10-02       Impact factor: 2.984

6.  Comparison of transoral robotic surgery with other surgeries for obstructive sleep apnea.

Authors:  Yung-An Tsou; Wen-Dien Chang
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.